Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahsa Abassi

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Journal of Neurovirology|July 7, 2019
Letter to the EditorMahsa Abassi, Ned Sacktor
The Lancet. Global Health|February 18, 2022
Fluvoxamine for the treatment of COVID-19David R Boulware, Mahsa Abassi
Medical Mycology Case Reports|December 14, 2017
Emerging fluconazole resistance: Implications for the management of cryptococcal meningitisEdward Mpoza, Joshua Rhein, Mahsa Abassi
Current Tropical Medicine Reports|August 18, 2015
Cryptococcal Meningitis: Diagnosis and Management UpdateMahsa Abassi, David R Boulware, Joshua Rhein
Journal of Fungi (Basel, Switzerland)|July 24, 2019
Diagnosis and Management of Central Nervous System Cryptococcal Infections in HIV-Infected AdultsCaleb Skipper, Mahsa Abassi, David R Boulware
Expert Review of Anti-Infective Therapy|January 24, 2017
Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settingsSarah Lofgren, Mahsa Abassi, Joshua Rhein, et al.
Open Forum Infectious Diseases|January 27, 2018
Cryptococcal Disease in the Era of "Test and Treat": Is There Cause for Concern?Mahsa Abassi, Joshua Rhein, David B Meya, et al.
Clinical Microbiology Reviews|November 28, 2023
Diagnosis and management of cryptococcal meningitis in HIV-infected adultsThomas C McHale, David R Boulware, John Kasibante, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2026
Evaluating Desirability of Outcome Ranking (DOOR) and Win Ratio for Hierarchical Composite Endpoints in Cryptococcal Meningitis TrialsBiyue Dai, Nicole Engen, Caleb P Skipper, et al.
Open Forum Infectious Diseases|August 18, 2019
Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction ModelSupavit Chesdachai, Radha Rajasingham, Melanie R Nicol, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Journal of Neurovirology|July 7, 2019
Letter to the EditorMahsa Abassi, Ned Sacktor
The Lancet. Global Health|February 18, 2022
Fluvoxamine for the treatment of COVID-19David R Boulware, Mahsa Abassi
Medical Mycology Case Reports|December 14, 2017
Emerging fluconazole resistance: Implications for the management of cryptococcal meningitisEdward Mpoza, Joshua Rhein, Mahsa Abassi
Current Tropical Medicine Reports|August 18, 2015
Cryptococcal Meningitis: Diagnosis and Management UpdateMahsa Abassi, David R Boulware, Joshua Rhein
Journal of Fungi (Basel, Switzerland)|July 24, 2019
Diagnosis and Management of Central Nervous System Cryptococcal Infections in HIV-Infected AdultsCaleb Skipper, Mahsa Abassi, David R Boulware
Expert Review of Anti-Infective Therapy|January 24, 2017
Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settingsSarah Lofgren, Mahsa Abassi, Joshua Rhein, et al.
Open Forum Infectious Diseases|January 27, 2018
Cryptococcal Disease in the Era of "Test and Treat": Is There Cause for Concern?Mahsa Abassi, Joshua Rhein, David B Meya, et al.
Clinical Microbiology Reviews|November 28, 2023
Diagnosis and management of cryptococcal meningitis in HIV-infected adultsThomas C McHale, David R Boulware, John Kasibante, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2026
Evaluating Desirability of Outcome Ranking (DOOR) and Win Ratio for Hierarchical Composite Endpoints in Cryptococcal Meningitis TrialsBiyue Dai, Nicole Engen, Caleb P Skipper, et al.
Open Forum Infectious Diseases|August 18, 2019
Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction ModelSupavit Chesdachai, Radha Rajasingham, Melanie R Nicol, et al.
Pageof 6